TOVX - Theriva Biologics, Inc.
0.81
-0.550 -67.901%
Share volume: 45,787,265
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.36
-0.55
-0.40%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-12-2024 | 03-06-2025 | |
| Total revenue | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | |
| nan% | |||
| Operating expenses | 5.036 M | 4.579 M | |
| Selling general and admin | 2.302 M | 1.694 M | |
| Research and development | 2.734 M | 2.885 M | |
| Total expenses | 7.887 M | 4.579 M | |
| -41.94% | |||
| Operating income | -7.887 M | -4.579 M | |
| Ebit | -7.884 M | -4.584 M | |
| Pretax income | -7.726 M | -4.446 M | |
| -42.45% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -7.726 M | -4.446 M | |
| 42.45% |
